Ditchcarbon
  • Contact
  1. Organizations
  2. Hypera Pharma
Public Profile
Pharmaceutical Preparation Manufacturing
BR
updated a month ago

Hypera Pharma

Company website

Hypera Pharma, a leading player in the Brazilian pharmaceutical industry, is headquartered in São Paulo, Brazil. Founded in 2010, the company has rapidly established itself as a key provider of prescription and over-the-counter medications, focusing on therapeutic areas such as central nervous system disorders, dermatology, and consumer health. With a diverse portfolio of well-known brands, Hypera Pharma distinguishes itself through its commitment to innovation and quality, ensuring that its products meet the highest standards. The company has achieved significant market presence, becoming one of the largest pharmaceutical companies in Brazil, and has garnered recognition for its strategic acquisitions and robust growth trajectory. Hypera Pharma continues to enhance its position in the industry by prioritising research and development, aiming to improve health outcomes for patients across the region.

DitchCarbon Score

How does Hypera Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

36

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Hypera Pharma's score of 36 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

56%

Let us know if this data was useful to you

Hypera Pharma's reported carbon emissions

In 2021, Hypera Pharma reported total carbon emissions of approximately 50,203 tonnes CO2e, with emissions distributed across various scopes: 25,418 tonnes CO2e from Scope 1, 8,666 tonnes CO2e from Scope 2, and 16,119 tonnes CO2e from Scope 3. This data reflects a slight increase from 2020, when total emissions were about 44,803 tonnes CO2e. Hypera Pharma has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2020 as the baseline year. This target has been validated by the Science Based Targets initiative (SBTi) and is consistent with the reductions necessary to limit global warming to 1.5°C. The company also plans to measure and address its Scope 3 emissions, which include indirect emissions from business travel, employee commuting, and waste generated in operations. Hypera Pharma's emissions data and climate commitments are sourced directly from Hypera S.A., with no data cascaded from a parent or related organization. The company is actively working towards its sustainability goals, reflecting a commitment to reducing its environmental impact in the pharmaceutical industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021
Scope 1
23,726,750
00,000,000
Scope 2
3,852,990
0,000,000
Scope 3
17,223,730
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hypera Pharma's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Hypera Pharma is in BR, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hypera Pharma is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Laboratorios Bago De Bolivia S.A.

BO
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Eurofarma

BR
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Burt's Bees, Inc.

US
•
Chemicals nec
Updated about 1 month ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251018.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy